Recent advances have highlighted that adiponectin, a well‐characterized insulin‐sensitizing adipokine, and its receptors, especially T‐cadherin (also known as H‐cadherin or CDH13), may resist obesity‐related carcinogenesis.4 Here, ADIPOQ is linked to obesity disorder.